Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Dermata Therapeutics, Inc.

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Mar-31-23Jun-30-22Mar-31-22Dec-31-21Sep-30-21Jun-30-21Mar-31-21
   10-Q10-Q10-Q10-Q10-KS-110-Q10-Q
Net income  -1.7-2.2-2.7-2.8-2.6-4.3-1.3-2.3
Stock-based compensation  0.10.10.30.22.10.10.11.2
Change in working capital   [+]-0.30.50.60.01.9 0.30.4
Other operating activities      -3.22.60.00.0
Cash from operations  -1.8-1.6-1.8-2.6-1.8-1.6-0.9-0.8
   
Capital expenditures  0.00.00.00.00.00.00.00.0
Cash from investing  0.00.00.00.00.00.00.00.0
   
Issuance of common stock, net  1.54.24.3     
Other cash from financing  0.00.00.0 0.0  1.6
Cash from financing  1.54.24.30.00.00.00.01.6
   
Free cash flow  -1.8-1.6-1.8-2.6-1.8-1.6-0.9-0.8
        Per share (diluted)  ($0.68)($1.67)($2.63)($5.01)($0.42)($0.32)($0.47)($0.41)
   
Cash paid for interest        0.00.0

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy